1. Introduction {#s0005}
===============

Myocardial infarction (MI) is a complex syndrome affected by multiple predisposing genetic and environmental factors [@b0005]. The association between *ApoE* polymorphisms and MI has drawn a lot of attention. ApoE is a multifunctional protein which plays a critical role in the metabolism of triglycerides and cholesterol [@b0010], [@b0015], and the corresponding gene is considered as a excellent candidate to investigate the etiology of MI [@b0020]. The gene is located at 19q13.2 and possesses three common alleles (ε2, ε3, ε4) and forms six genotypes (ε2/ε2, ε2/ε3, ε2/ε4, ε3/ε3, ε3/ε4 and ε4/ε4) [@b0025]. As the previous studies, the *ApoE* polymorphisms were found to affect ApoE transcription and the levels of cholesterol and triglyceride [@b0030], [@b0035], which was the main underlying risk factor of MI. However, the results of the earlier studies were inconsistent. Therefore, a system review and meta-analysis by collecting and sorting the previously published studies was conducted.

2. Materials and methods {#s0010}
========================

2.1. Identification and eligibility of relevant studies {#s0015}
-------------------------------------------------------

The online medical databases PubMed and Web of Science were used, using the search term "ApoE/Apolipoprotein E", "polymorphism/genetic variation" and "myocardial infarction/MI". The last retrieval was conducted in January 2015. The literatures were limited to papers in English. In addition, studies were identified by manual search of the references listed in the retrieved studies. The inclusion criteria were listed as follows: (1) case--control studies with either a population-based or a hospital-based design; (2) studies evaluated association between the *ApoE* polymorphisms and cancer risk; (3) present sufficient data to calculate an odds ratio (OR) with 95% confidence interval (CI); (4) not republished data. Moreover, the studies without raw data or those that were case-only studies, case reports, editorials and review articles (including meta-analyses) were eliminated.

2.2. Data extraction {#s0020}
--------------------

The following detail information were extracted from each study enrolled in this study by two investigators (YLW and LZ) independently: the first author's last name, year of publication, country of subjects, ethnicity, the source of controls, genotyping method, matching numbers of genotyped cases and controls and *P* for Hardy--Weinberg equilibrium (HWE). Furthermore, the disagreements were discussed among all authors and resolved with consensus.

2.3. Statistical analysis {#s0025}
-------------------------

The association of the *ApoE* polymorphism and risk of myocardial infarction was estimated by calculating the pooled ORs and 95%CI. The pooled ORs were estimated for seven genetic models (ε2/ε2 vs. ε3/ε3, ε2/ε3 vs. ε3/ε3, ε2/ε4 vs. ε3/ε3, ε3/ε4 vs. ε3/ε3, ε4/ε4 vs. ε3/ε3, ε2 allele vs. ε3 allele and ε4 allele vs. ε3 allele). Stratified analyses were performed by ethnicity ('other ethnicity' group was defined as those ethnicities that contained only one study). Heterogeneity across the studies was evaluated by using the Chi-square test based *Q*-statistic test [@b0040], and it was considered significant when *P*~heterogeneity~(*P*~h~) \< 0.05. The data were combined using random-effects (the DerSimonian and Laird method) in the presence of heterogeneity (*P* \< 0.05 or *I*^2^ \> 50%) and fixed-effects (the Mantel--Haenszel method) models were used in absence of heterogeneity (*P* \> 0.05 or *I*^2^ \< 50%) [@b0045]. Furthermore, the sensitivity analysis was used to assess the stability of results, and publication bias was analyzed by Begg's funnel plot and Egger's regression test [@b0050]. Additionally, HWE was used to assess the genotype frequencies of the polymorphism by the chi-square test. All statistical tests were performed with STATA 11.0 and all the *P* values were two-sided.

3. Results {#s0030}
==========

3.1. Characteristics of studies {#s0035}
-------------------------------

Based on the search strategy, 571 potentially eligible studies were identified in the initial search. Among these, 22 studies were enrolled in this meta-analysis based on the inclusion criteria [@b0055], [@b0060], [@b0065], [@b0070], [@b0075], [@b0080], [@b0085], [@b0090], [@b0095], [@b0100], [@b0105], [@b0110], [@b0115], [@b0120], [@b0125], [@b0130], [@b0135], [@b0140], [@b0145], [@b0150], [@b0155], [@b0160] ([Fig. 1](#f0005){ref-type="fig"}). The study by Luc et al. [@b0150] investigated in four countries and was divided into four studies. The main characteristics of the enrolled 22 studies are summarized in [Table 1](#t0005){ref-type="table"}.

3.2. Quantitative synthesis {#s0040}
---------------------------

In the pooled analysis, significant association was observed between *ApoE* polymorphism and risk of myocardial infarction. The main results were presented in [Table 2](#t0010){ref-type="table"}, and the result of ε2/ε3 vs. ε3/ε3 was also shown in [Fig. 2](#f0010){ref-type="fig"}.

Additionally, the subgroup analysis by ethnicity was also conducted, and significant associations with myocardial infarction were observed in Caucasian ([Fig.3](#f0015){ref-type="fig"}) and Asian population. The main results were presented in [Table 2](#t0010){ref-type="table"}.

3.3. Sensitivity analysis {#s0045}
-------------------------

To assess the stability of the results and assess the source of the heterogeneity, the sensitivity analysis was performed by omitting individual eligible study to reflect the influence of the individual data on the summary ORs. The pooled ORs were not altered for all comparison models. Among all the enrolled studies, four studies did not follow HWE, the corresponding summary ORs were not materially altered with or without these studies. Therefore, the results of current study were statistically robust. The result of ε2/ε2 vs. ε3/ε3 was shown in [Fig. 4](#f0020){ref-type="fig"}.

3.4. Heterogeneity analysis {#s0050}
---------------------------

There was significant between-study heterogeneity in ε2/ε2 vs. ε3/ε3 (*P* = 0.001, *I*^2^ = 63.4), ε2/ε3 vs. ε3/ε3 (*P* = 0.005, *I*^2^ = 48.3), ε3/ε4 vs. ε3/ε3 (*P* = 0.000, *I*^2^ = 58.0), ε2 allele vs. ε3 allele (*P* = 0.000, *I*^2^ = 64.3) and ε4 allele vs. ε3 allele (*P* = 0.000, *I*^2^ = 65.5). In contract, no significant heterogeneity was observed in other two genetic models (ε2/ε4 vs. ε3/ε3: *P* = 0.750, *I*^2^ = 0.0; ε4/ε4 vs. ε3/ε3: *P* = 0.194, *I*^2^ = 20.6). In order to detect the sources of heterogeneity, the sensitivity analysis was performed based on HWE and ethnicity. However, the heterogeneity was not materially altered. As a consequence, we conducted a Galbraith plot to graphically assess the source of heterogeneity. The results indicated that a total of eight studies contributed to the heterogeneity. Two studies were the main sources for ε2/ε2 vs. ε3/ε3 [@b0100], [@b0160] ([Fig. 5](#f0025){ref-type="fig"}), three studies for ε2/ε3 vs. ε3/ε3 [@b0075], [@b0105], [@b0135], four studies for ε3/ε4 vs. ε3/ε3 [@b0080], [@b0095], [@b0135], [@b0160], four studies for ε2 allele vs. ε3 allele [@b0075], [@b0105], [@b0135], [@b0160] and five studies for ε4 allele vs. ε3 allele [@b0055], [@b0080], [@b0095], [@b0135], [@b0160], and after removal of these outlier studies, the heterogeneity was effectively removed (ε2/ε2 vs. ε3/ε3: *P* = 0.640, *I*^2^ = 0.0; ε2/ε3 vs. ε3/ε3: *P* = 0.828, *I*^2^ = 0.0; ε3/ε4 vs. ε3/ε3: *P* = 0.800, *I*^2^ = 0.0; ε2 allele vs. ε3 allele: *P* = 0.651, *I*^2^ = 0.0; ε4 allele vs. ε3 allele: *P* = 0.566, *I*^2^ = 0.0). Meanwhile, the corresponding pooled ORs were not materially altered in all comparisons. As a consequence, the results of heterogeneity analysis indicated that our results were statistically robust and credible.

3.5. Publication bias {#s0055}
---------------------

To evaluate the publication bias of enrolled studies, the Begg's funnel plot and Egger's test were performed. The shapes of funnel plots did not show any obvious asymmetry in all genetic models. Therefore, the Egger's test was performed to provide statistical evidence of funnel plot symmetry, and the results confirmed the absence of publication bias ([Table 3](#t0015){ref-type="table"}).

4. Discussion {#s0060}
=============

A total of 22 studies were included in this meta-analysis to investigate the association between *ApoE* polymorphisms and MI. The results of the overall studies showed that the ε2/ε3 genotype was associated with a decreased risk of MI, while the ε3/ε4 and ε4/ε4 genotypes were associated with an increased risk of MI. The current results were in accord with the previous observers, which support the ε4 allele as a risk factor of MI [@b0080], [@b0165], [@b0170]. For the ε2 allele, it was found significantly protective against MI [@b0060], [@b0105]. The discrepancy of the effect on MI risk between different *ApoE* genotypes might be supported by earlier studies [@b0175], [@b0180]. It provided evidence that the ApoE E4 coding by ε4 allele exhibits enhanced transfer from HDL to TG-rich lipoproteins, promoting hepatic remnant clearance by apoE receptors and decreasing LDLR, thereby increasing cholesterol levels. On the contrary, the ApoE E2 coding by ε2 allele binds LDLR poorly, which can increase the LDLR numbers, thereby lowering cholesterol level. A previous meta-analysis showed no significant association between ε2 carriers and MI risk (ε2 carriers vs. ε3/ε3: OR = 0.90, 95%CI = 0.76--1.06, *P* = 0.120), whereas an increased MI risk with ε4 carriers (ε4 carriers vs. ε3/ε3: OR = 1.18, 95%CI = 1.05--1.33, *P* = 0.003) [@b0185]. By comparison, our results were not completely consistent with previous meta-analysis. The discrepancy may partly result from the genetic diversity among ethnicities.

Furthermore, the subgroup analysis by ethnicity showed a decreased MI risk in ε2 carriers, while an increased MI risk in ε4 carriers compared with ε3 carriers in both Asian and Caucasian population. These results were consistent with the studies enrolled in our meta-analysis [@b0055], [@b0060], [@b0075], [@b0095], [@b0130], [@b0150]. Furthermore, sensitivity analysis was also performed to make sure whether modification of the inclusion criteria of the meta-analysis affected the final results. The results showed that corresponding pooled ORs were not materially altered in all genetic models which indicated that the results were statistically robust.

Heterogeneity is a potentially important factor to influence the interpretation of the current results. In this meta-analysis, significant heterogeneity existed in ε2/ε2 vs. ε3/ε3, ε2/ε3 vs. ε3/ε3, ε3/ε4 vs. ε3/ε3, ε2 allele vs. ε3 allele and ε4 allele vs. ε3 allele. Common reasons of heterogeneity may attribute to the diversity in design, study quality, sample-sizes, genotyping methods, inclusion criteria and some studies without HWE. To explore the sources of heterogeneity, we first performed the sensitivity analyses based on HWE and ethnicity. However, the heterogeneity was not effectively removed. Therefore, a Galbraith plot was performed to further evaluate the source of heterogeneity. After excluding eight outlier studies, the heterogeneity was effectively removed. Moreover, the corresponding pooled ORs were not materially altered in all comparisons, which also suggested that our results were statistically robust.

Some limitations of the meta-analysis should be addressed. Firstly, the potential factors such as gender, age, smoking, drinking, living habits were not considered in this meta-analysis. Secondly, between-study heterogeneity should be paid attention, which may affect the results. Thirdly, only studies in English were enrolled in this meta-analysis, which may lose some studies in other languages consistent with inclusion criteria. Regardless of such limitations, this meta-analysis still had some advantages. Firstly, all enrolled studies were consistent with inclusion criteria well. Secondly, no publication bias was observed indicating that the whole pooled results might be unbiased.

In conclusion, the current meta-analysis of 22 studies indicated that *ApoE* ε2 allele was a protective factor of MI, while ε4 allele was a dangerous factor of MI, especially in Asian and Caucasian population. However, the results should be further conformed in well-designed, unbiased, powered studies.
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###### 

The characteristics of the enrolled studies in this meta-analysis.

  First author   Year   Country       Ethnicity   Source of control   Genotyping method               Sample size (cases/controls)   HWE
  -------------- ------ ------------- ----------- ------------------- ------------------------------- ------------------------------ ---------
  Tanguturi      2013   India         Asian       PB                  PCR-RFLP                        202/210                        0.097
  Anand          2009   Mixed         Mixed       Mixed               IlluminaGoldenGate technology   4017/4017                      0.091
  Al-Bustan      2009   Kuwaiti       Asian       HB                  PCR-RFLP                        88/122                         \<0.050
  Koch           2008   Germany       Caucasian   PB                  TaqMan                          3657/1211                      0.558
  Ranjith        2004   Indian        African     PB                  PCR-RFLP                        195/300                        \<0.050
  Keavney        2004   UK            Caucasian   PB                  PCR-RFLP                        4685/3460                      --
  Keavney        2003   UK            Caucasian   PB                  PCR-RFLP                        4484/5757                      0.463
  Mamotte        2003   Australia     Caucasian   PB                  PCR-RFLP                        359/639                        0.732
  Wang           2001   Xinjiang      Asian       PB                  PCR-RFLP                        54/71                          0.479
  Raslova        2001   Bratislava    Caucasian   PB                  PCR-RFLP                        71/71                          0.183
  Batalla        2000   Asturias      Caucasian   PB                  PCR-RFLP                        220/200                        0.776
  Joven          1998   Spanish       Caucasian   PB                  PCR-RFLP                        250/250                        0.109
  Luc            1994   Belfast       Caucasian   PB                  NA                              183/176                        0.405
  Luc            1994   Lille         Caucasian   PB                  NA                              64/150                         0.932
  Luc            1994   Strasbourg    Caucasian   PB                  NA                              187/172                        0.35
  Luc            1994   Toulouse      Caucasian   PB                  NA                              140/182                        0.698
  Lenzen         1986   NA            Caucasian   PB                  NA                              570/624                        0.081
  Kolovou        2002   Greek         Caucasian   PB                  PCR-RFLP                        124/240                        0.552
  Kumar          2003   North India   Asian       PB                  PCR-RFLP                        35/45                          \<0.050
  Baum           2006   Hong Kong     Asian       HB                  PCR-RFLP                        234/336                        0.659
  Nakai          1998   Japan         Asian       PB                  PCR-RFLP                        254/422                        0.175
                                                                                                                                     
  Hergenc        1995   Turkish       Caucasian   PB                  PCR-RFLP                        50/60                          0.117
  Utermann       1984   Germany       Caucasian   PB                  NA                              523/1031                       \<0.050

NA: not available; PB: population based; HB: hospital based; PCR-RFLP: restriction fragment length polymorphism; HWE: Hardy--Weinberg equilibrium. --: the data of the study are not enough.

###### 

Stratified analyses of the *ApoE* polymorphism and MI risk.

  Variables     n[a](#tblfn1){ref-type="table-fn"}   ε2/ε2 vs. ε3/ε3                                    ε2/ε3 vs. ε3/ε3   ε2/ε4 vs. ε3/ε3   ε3/ε4 vs. ε3/ε3                                        ε4/ε4 vs. ε3/ε3   ε2 allele vs. ε3 allele   ε4 allele vs. ε3 allele                                                                                                                                                                                                                                                                  
  ------------- ------------------------------------ -------------------------------------------------- ----------------- ----------------- ------------------------------------------------------ ----------------- ------------------------- ------------------------- ------- ----- ------------------------------------------------------ ------- ------ ---------------------- ------- ------ ------------------------------------------------------ ------- ------ ------------------------------------------------------ ------- ------
  Total         23                                   0.56(0.31,1.02)[c](#tblfn3){ref-type="table-fn"}   0.001             63.4              **0.79(0.70,0.91)**[c](#tblfn3){ref-type="table-fn"}   0.005             48.3                      0.96(0.81,1.14)           0.750   0.0   **1.20(1.08,1.34)**[c](#tblfn3){ref-type="table-fn"}   0.000   58.0   **1.39(1.19,1.64)**    0.194   20.6   **0.74(0.65,0.85)**[c](#tblfn3){ref-type="table-fn"}   0.000   64.3   **1.22(1.11,1.35)**[c](#tblfn3){ref-type="table-fn"}   0.000   65.5
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  *Ethnicity*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Caucasian     15                                   0.64(0.27,1.51)[c](#tblfn3){ref-type="table-fn"}   0.000             76.5              **0.83(0.72,0.96)**[c](#tblfn3){ref-type="table-fn"}   0.026             46.1                      1.05(0.99,1.12)           0.390   5.6   1.12(1.00,1.26)[c](#tblfn3){ref-type="table-fn"}       0.007   54.0   **1.26(1.05,1.52)**    0.914   0.0    **0.77(0.65,0.91)**[c](#tblfn3){ref-type="table-fn"}   0.000   70.6   **1.11(1.01,1.21)**[c](#tblfn3){ref-type="table-fn"}   0.041   42.6
  Asian         6                                    0.52(0.18,1.49)                                    0.866             0.0               0.68(0.34,1.37)[c](#tblfn3){ref-type="table-fn"}       0.022             61.9                      1.16(0.57,2.35)           0.864   0.0   **1.52(1.19,1.93)**                                    0.333   12.8   **5.67(2.68,12.02)**   0.553   0.0    **0.58(0.43,0.79)**                                    0.071   50.7   **1.92(1.26,2.92)**[c](#tblfn3){ref-type="table-fn"}   0.004   70.9
  Other         2                                    **0.40(0.20,0.83)**                                0.704             0.0               **0.79(0.68,0.93)**                                    0.629             0.0                       0.94(0.77,1.14)           0.555   0.0   1.72(0.69,4.27)[c](#tblfn3){ref-type="table-fn"}       0.001   91.3   1.34(0.91,1.98)        0.186   42.7   **0.77(0.67,0.89)**                                    0.388   0.0    1.42(0.85,2.38)[c](#tblfn3){ref-type="table-fn"}       0.022   81.0

Statistically significant results were in bold.

Number of comparisons.

*P* value of *Q*-test for heterogeneity test.

Random-effect model was applied when *P* value for heterogeneity \<0.05; otherwise, fixed-effect model was applied.

###### 

Egger's test for *ApoE*polymorphism.

  Egger's test   ε2/ε2 vs. ε3/ε3   ε2/ε3 vs. ε3/ε3   ε2/ε4 vs. ε3/ε3   ε3/ε4 vs. ε3/ε3   ε4/ε4 vs. ε3/ε3
  -------------- ----------------- ----------------- ----------------- ----------------- -----------------
  *t*            −0.53             −0.73             0.6               1.46              0.48
  *p*            0.607             0.474             0.554             0.159             0.638

[^1]: These authors contributed equally to this work.
